Mgo One Seven LLC Adamis Pharmaceuticals Corp Transaction History

Mgo One Seven LLC

  • $2.26 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 09, 2018
BUY
$2.25 - $4.8 $23,208 - $49,512
10,315 Added 3438.33%
10,615 $37,000
Q4 2017

Feb 16, 2018
BUY
$3.5 - $5.65 $1,050 - $1,695
300
300 $1,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email